Item 16. Form 10-K Summary

Form 10-K Summary

None.

Index to Financial Statements

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange

Act of 1934, the Registrant has duly

caused this report to be signed on its behalf by the undersigned,

thereunto duly authorized.

Henry Schein, Inc.

By: /s/ STANLEY M. BERGMAN

Stanley M. Bergman

Chairman and Chief Executive Officer

February 25, 2025

Pursuant to the requirements of the Securities Exchange Act of 1934, this

report has been signed below by the

following persons on behalf of the Registrant and in the capacities and on

the dates indicated.

Signature

Capacity

Date

/s/ STANLEY M. BERGMAN

Chairman, Chief Executive Officer

February 25, 2025

Stanley M. Bergman

and Director (principal executive officer)

/s/ RONALD N. SOUTH

Senior Vice President, Chief

Financial Officer

February 25, 2025

Ronald N. South

(principal financial and accounting officer)

/s/ MARK E. MLOTEK

Executive Vice President,

Chief Strategic Officer, and

February 25, 2025

Mark E. Mlotek

Director

/s/ MOHAMAD ALI

Director

February 25, 2025

Mohamad Ali

/s/ DEBORAH DERBY

Director

February 25, 2025

Deborah Derby

/s/ CAROLE T. FAIG

Director

February 25, 2025

Carole T. Faig

/s/ JOSEPH L. HERRING

Director

February 25, 2025

Joseph L. Herring

/s/ ROBERT J. HOMBACH

Director

February 25, 2025

Robert J. Hombach

/s/ KURT P.

KUEHN

Director

February 25, 2025

Kurt P.

Kuehn

/s/ PHILIP A. LASKAWY

Director

February 25, 2025

Philip A. Laskawy

/s/ ANNE H. MARGULIES

Director

February 25, 2025

Anne H. Margulies

/s/ CAROL RAPHAEL

Director

February 25, 2025

Carol Raphael

/s/ SCOTT SEROTA

Director

February 25, 2025

Scott Serota

/s/ BRADLEY T. SHEARES,

PH.D.

Director

February 25, 2025

Bradley T. Sheares,

Ph.D.

/s/ REED V.

TUCKSON, M.D., FACP

Director

February 25, 2025

Reed V.

Tuckson, M.D., FACP